Heightening awareness of myasthenia gravis, its presentation, symptoms and new treatments that are now available.
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D014837:Voluntary Health Agencies
D002800:Cholinesterase Inhibitors; D011729:Pyridostigmine Bromide